No insider purchase over the last 90 days. The latest, by OESTERLE STEPHEN N, was filed 29 Feb 2016.
Every trade that managers of HeartWare International, Inc. disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for HeartWare International, Inc. The previous disclosure was published on 24 August 2016.
Looking back to 2016, when coverage begins, insiders filed 1 purchase and 41 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 103 declarations
HeartWare International, Inc. is a company focused on developing medical devices for the treatment of heart diseases. It primarily concentrates on cardiac support systems for patients with heart failure.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2015 | 276.8 m USD | -72.8 m USD | n.d. | 10-K |
| Dec 2014 | 278.4 m USD | -19.4 m USD | n.d. | 10-K |
| Dec 2013 | 207.9 m USD | -59.3 m USD | n.d. | 10-K |
| Dec 2012 | 110.9 m USD | -87.7 m USD | n.d. | 10-K |
| Dec 2011 | 82.8 m USD | -55.1 m USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.